Chemoembolization Follow-up of Hepatocellular Carcinoma with MR Imaging: Usefulness of Evaluating Enhancement Features on One-month Posttherapy MR Imaging for Predicting Residual Disease

Conclusions: This investigation shows high accuracy for using tumor enhancement features on 1-month posttherapy MR imaging to predict residual disease after chemoembolization of HCC. (Source: Journal of Vascular and Interventional Radiology : JVIR)

View full post on MedWorm: HIPAA